Clinical Trials Browser

Interventional × carfilzomib × Endocrine × Clear all

NCT02318784 2023-12-05

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

Phase 2 Completed

62 enrolled 10 charts

Carcinoid Tumor, Carcinoma, Neuroendocrine